Search for: "Apotex" Results 661 - 680 of 1,046
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
6 Jul 2010, 6:03 pm by Duncan
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
16 Jun 2010, 10:30 am by FDABlog HPM
SA4361 and its predecessors appear to be rooted in a paper Apotex issued early last year. [read post]
11 Jun 2010, 2:15 pm
Advanced Magnetic Closures ("AMC") sued Rome Fastener ("Romag") for clasping 5,572,773, claiming "a magnetic snap fastener commonly used in women's handbags. [read post]
26 May 2010, 3:01 pm by Oliver G. Randl
In its written submission, […] Apotex declares that it has carried out four trials for the purpose of presenting them in the law suite in the UK and explains how the experimental conditions under which the trials were carried out could be guaranteed. [read post]
19 May 2010, 6:15 am
(Patent Docs)   Products Actos and Actoplus Met (Pioglitazone) - Sandoz and Takeda settle patent dispute over Actos and Actoplus Met (Patent Docs) Cozaar / Hyzaar (Losartan) – US: DC Circuit denies FDA’s petition for panel rehearing and rehearing en banc; Roxane/Apotex case continues (FDA Law Blog) Entocort (Budesonide) – US: Teva reaches settlement agreement with AstraZeneca regarding generic Entocort capsules (SmartBrief) Levaquin (Levafloxicin) - US: CAFC decision… [read post]
14 May 2010, 4:00 am by FDABlog HPM
”  (A few years ago, Apotex challenged this interpretation at FDA and in court, but the issue was eventually dropped without a decision.) [read post]
6 May 2010, 9:43 am
The Food, Drug, and Cosmetic Act (“FDCA”) was enacted in 1938 to regulate, among other things, the drug and medical device industry in order to ensure the safe and effective design, manufacture, sale and labeling of such products. [read post]
5 May 2010, 4:46 am
., Mylan, Glenmark, Cobalt, Aurobindo and Apotex  (Patent Docs) (GenericsWeb) Cydectin (Moxidectin) – US: Federal Circuit sides with FDA and PTO in decision; Court rules that approval phase begins when administrative NADA is initially submitted (FDA Law Blog) Effexor (Venlafaxine) – US: Patent infringement complaint filed in response to Para IV certification: Wyeth LLC v. [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
  The FTC charged that, among other things, BMS failed to disclose (as part of a patent settlement with Apotex) that the company orally promised that it would not compete with Apotex during the first 180-days that Apotex marketed its generic version of PLAVIX. [read post]